Juan Luis Fernández Masip: Reconnecting With the Australia and New Zealand Hematology Community at Blood 2026
Juan Luis Fernández Masip, Cell Therapy Medical Scientist at Gilead Science, shared a post on LinkedIn:
“After six years away from Blood, it was a privilege to return and reconnect with the inspiring Australia and New Zealand Hematology community at Blood 2026.
Making the experience even more memorable, this was also my first visit to Auckland.
The conversations, scientific discussions, and exchange of perspectives reinforced how much we can learn when we remain curious and open to new ideas.
Leadership is not about having all the answers. It is about continuously learning, challenging our thinking, and growing alongside others. Grateful for the insights, connections, and renewed energy this meeting has provided.
See you in Adelaide in 2027.”
Stay updated with Hemostasis Today.
-
Oct 24, 2026, 05:46James Posada: Demonstrating the Benefits of Nuclease Therapy in Ischemic Stroke
-
Oct 24, 2026, 05:43No One Should Navigate Von Willebrand Disease Alone – EHC
-
Oct 24, 2026, 05:42Joseph R. Shaw: Thrombin Generation as a Tool for Coagulation Phenotyping in Critically Ill Patients
-
Oct 24, 2026, 05:39Ani Mebalds: Advancing the Availability of Cryopreserved Blood Products at AABB
-
Oct 23, 2026, 17:45Lucy Brook: Had the Privilege of Attending the Blood 2026 Conference with New Zealand Blood Service
-
Oct 23, 2026, 16:05Platelet Secretion Defects and Their Role in the Diagnosis of Bleeding Disorders
-
Oct 23, 2026, 16:00Hemophilia Alliance team in New Orleans at the ATHN Data Summit
-
Oct 23, 2026, 15:49Brian Sapp: Why Exact Calf Vein Naming Is Critical for DVT Diagnosis?
-
Oct 23, 2026, 15:33Smitirupa Mishra: A Systematic Approach to Bone Marrow Examination